International Flavors & Fragrances INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
International Flavors & Fragrances Inc. announces the sale of its Food Ingredients business to CVC Capital Partners, retaining a 10% equity interest, with the transaction expected to close by Q2 2027.
NYSE
International Flavors & Fragrances Inc. announced robust second quarter 2026 financial results, driven by volume growth and margin execution, alongside the strategic divestiture of its Food Ingredients business.
NYSE
International Flavors & Fragrances Inc. has agreed to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, as part of a strategic portfolio transformation.
NYSE
International Flavors & Fragrances Inc. announced strong first quarter 2026 financial results, driven by volume growth across all segments and improved profitability, while reaffirming full-year guidance.
NYSE
International Flavors & Fragrances Inc. held its Annual Meeting of Shareholders on April 29, 2026, where directors were elected, the independent auditor was ratified, and executive compensation was approved in an advisory vote.
NYSE
International Flavors & Fragrances Inc. (IFF) reported solid fourth quarter and full year 2025 financial results, meeting commitments despite challenges, and initiated the sale process for its Food Ingredients segment.
NYSE
International Flavors & Fragrances Inc. adopted amended and restated bylaws, updating corporate governance, shareholder meeting procedures, and director indemnification.
NYSE
International Flavors & Fragrances Inc. reported an 8% decline in third-quarter sales to $2.7 billion but saw adjusted operating EBITDA improve 7% on a comparable currency-neutral basis, reaffirming full-year guidance.
NYSE
International Flavors & Fragrances Inc. announced the appointment of Brett Icahn and Dr. Richard Mulligan to its Board of Directors, effective October 20, 2025, following the departures of Vincent Intrieri and Margarita Palu-Hernández.
NYSE
International Flavors & Fragrances Inc. announced the appointment of Marc Birenkrant as Controller & Chief Accounting Officer, effective August 10, 2025.
NYSE
International Flavors & Fragrances Inc. (IFF) announced robust second-quarter 2025 financial results, including significant profit growth and a new $500 million share repurchase program, while reaffirming full-year guidance.
NYSE
International Flavors & Fragrances Inc. (IFF) has appointed Jesus Mantas and Paul Fribourg to its board of directors, effective July 29, 2025.
NYSE
International Flavors & Fragrances Inc. (IFF) has announced the appointment of Virginia Drosos, former CEO of Signet Jewelers Ltd., to its Board of Directors, effective June 16, 2025.
NYSE
International Flavors & Fragrances Inc. held its annual shareholder meeting on May 1, 2025, where shareholders elected directors, ratified the selection of PricewaterhouseCoopers LLP as the company's auditor, and approved executive compensation.
NYSE
International Flavors & Fragrances Inc. (IFF) announced its first quarter 2025 financial results, showcasing growth in several segments but impacted by a significant goodwill impairment.
NYSE
International Flavors & Fragrances Inc. (IFF) announces a reorganization of its internal structure effective January 1, 2025, leading to updated reportable segments and recast 2024 financials for comparison.
NYSE
International Flavors & Fragrances Inc. (IFF) reports the resignation of Executive Vice President, General Counsel, and Corporate Secretary Jennifer Johnson, effective July 1, 2025, to ensure a smooth transition.
NYSE
International Flavors & Fragrances Inc. (IFF) reports the departure of Simon Herriott, President of Health & Biosciences, and the appointment of Leticia Goncalves Loureno as his successor.
NYSE
International Flavors & Fragrances (IFF) reported its fourth quarter and full year 2024 financial results, highlighting a solid performance driven by strong top and bottom-line growth and providing 2025 financial guidance.
NYSE
International Flavors & Fragrances Inc. (IFF) has announced significant changes to its board of directors, including the appointment of three new members and the retirement of three current directors.
NYSE
International Flavors & Fragrances Inc. has announced the appointment of Michael DeVeau as its new Chief Financial Officer, succeeding Glenn Richter, who will retire on December 31, 2024.
NYSE
International Flavors & Fragrances Inc. (IFF) announced robust third-quarter 2024 financial results, driven by volume growth and productivity gains, leading to an increased full-year financial outlook.
NYSE
International Flavors & Fragrances Inc. (IFF) reported improved second-quarter results, driven by volume growth and productivity gains, leading to an increase in full-year sales and adjusted operating EBITDA guidance.
NYSE
International Flavors & Fragrances Inc. has appointed Margarita Palu-Hernández to its board of directors, effective June 3, 2024, filling a vacancy as part of a prior agreement.
NYSE
International Flavors & Fragrances Inc. held its annual shareholder meeting on May 1, 2024, where directors were elected, the auditor was ratified, executive compensation was approved, and a stock award plan was approved.
NYSE
International Flavors & Fragrances Inc. (IFF) announced its first quarter 2024 financial results, showing growth in sales and profitability, and has increased its full-year guidance.
NYSE
International Flavors & Fragrances Inc. (IFF) CFO Glenn Richter has announced his retirement, effective December 31, 2024, prompting a search for his successor.
NYSE
International Flavors & Fragrances Inc. announced that Simon Herriott will step down as President of the Scent division, effective April 1, 2024, while remaining President of Health & Biosciences.
NYSE
International Flavors & Fragrances Inc. (IFF) has agreed to sell its Pharma Solutions business to Roquette for an enterprise value of up to $2.85 billion.
NYSE
International Flavors & Fragrances Inc. reported a net loss for both the fourth quarter and full year 2023, driven by a significant goodwill impairment, while also showing some positive trends in adjusted operating EBITDA and sales growth in certain segments.